| 101 |
32308804 | Plumbagin Enhances the Anticancer Efficacy of Cisplatin by Increasing Intracellular ROS in Human Tongue Squamous Cell Carcinoma. | 2020 |
1 |
| 102 |
32314115 | SDC1 promotes cisplatin resistance in hepatic carcinoma cells via PI3K-AKT pathway. | 2020 Jul |
1 |
| 103 |
32323781 | MicroRNA‑22 mediates the cisplatin resistance of osteosarcoma cells by inhibiting autophagy via the PI3K/Akt/mTOR pathway. | 2020 Apr |
8 |
| 104 |
32328192 | LncRNA UCA1 promotes cisplatin resistance in gastric cancer via recruiting EZH2 and activating PI3K/AKT pathway. | 2020 |
3 |
| 105 |
32334286 | G-5555 synergized miR-485-5p to alleviate cisplatin resistance in ovarian cancer cells via Pi3k/Akt signaling pathway. | 2020 Aug |
5 |
| 106 |
32368441 | The inhibition of MARK2 suppresses cisplatin resistance of osteosarcoma stem cells by regulating DNA damage and repair. | 2020 Aug |
2 |
| 107 |
32411595 | Activation PDGFR-α/AKT Mediated Signaling Pathways in Oral Squamous Cell Carcinoma by Mesenchymal Stem/Stromal Cells Promotes Anti-apoptosis and Decreased Sensitivity to Cisplatin. | 2020 |
2 |
| 108 |
32422572 | MK2206 Enhances Cisplatin-Induced Cytotoxicity and Apoptosis in Testicular Cancer Through Akt Signaling Pathway Inhibition. | 2020 Jul |
5 |
| 109 |
32424818 | DMBT1 suppresses cell proliferation, migration and invasion in ovarian cancer and enhances sensitivity to cisplatin through galectin-3/PI3k/Akt pathway. | 2020 Aug |
1 |
| 110 |
32428872 | Amphiregulin promotes cisplatin chemoresistance by upregulating ABCB1 expression in human chondrosarcoma. | 2020 May 19 |
3 |
| 111 |
32458975 | SIK2 Promotes Cisplatin Resistance Induced by Aerobic Glycolysis in Breast Cancer Cells through PI3K/AKT/mTOR Signaling Pathway. | 2020 May 27 |
3 |
| 112 |
32509178 | MARK2 enhances cisplatin resistance via PI3K/AKT/NF-κB signaling pathway in osteosarcoma cells. | 2020 |
1 |
| 113 |
32521857 | Cinnamolide sesquiterpene lactone suppresses in vitro and in vivo cancer cell growth in cisplatin-resistant human cervical carcinoma cells by inducing mitochondrial mediated apoptosis, caspase activation, loss of MMP and targeting Akt/β-Catenin signaling pathway. | 2020 Mar-Apr |
1 |
| 114 |
32536824 | SNHG16 promotes tumorigenesis and cisplatin resistance by regulating miR-338-3p/PLK4 pathway in neuroblastoma cells. | 2020 |
1 |
| 115 |
32565935 | Ubiquitin-specific peptidase 17 promotes cisplatin resistance via PI3K/AKT activation in non-small cell lung cancer. | 2020 Jul |
2 |
| 116 |
32593915 | Testicular cancer: Determinants of cisplatin sensitivity and novel therapeutic opportunities. | 2020 Aug |
1 |
| 117 |
32627280 | Deoxyshikonin inhibits cisplatin resistance of non-small-cell lung cancer cells by repressing Akt-mediated ABCB1 expression and function. | 2020 Oct |
3 |
| 118 |
32673286 | Osthole resensitizes CD133+ hepatocellular carcinoma cells to cisplatin treatment via PTEN/AKT pathway. | 2020 Jul 16 |
2 |
| 119 |
32678482 | AKR1C2 acts as a targetable oncogene in esophageal squamous cell carcinoma via activating PI3K/AKT signaling pathway. | 2020 Sep |
1 |
| 120 |
32715509 | Curcumol improves cisplatin sensitivity of human gastric cancer cells through inhibiting PI3K/AKT pathway. | 2020 Jul 26 |
1 |
| 121 |
32742380 | MicroRNA-654-3p enhances cisplatin sensitivity by targeting QPRT and inhibiting the PI3K/AKT signaling pathway in ovarian cancer cells. | 2020 Aug |
1 |
| 122 |
32784919 | Anthocyanins Isolated from Vitis coignetiae Pulliat Enhances Cisplatin Sensitivity in MCF-7 Human Breast Cancer Cells through Inhibition of Akt and NF-κB Activation. | 2020 Aug 9 |
5 |
| 123 |
32800561 | Baicalein enhanced cisplatin sensitivity of gastric cancer cells by inducing cell apoptosis and autophagy via Akt/mTOR and Nrf2/Keap 1 pathway. | 2020 Oct 20 |
1 |
| 124 |
32819590 | GDC-0980 (apitolisib) treatment with gemcitabine and/or cisplatin synergistically reduces cholangiocarcinoma cell growth by suppressing the PI3K/Akt/mTOR pathway. | 2020 Sep 3 |
1 |
| 125 |
32826249 | PSAT1 Upregulation Contributes to Cell Growth and Cisplatin Resistance in Cervical Cancer Cells via Regulating PI3K/AKT Signaling Pathway. | 2020 Jul |
1 |
| 126 |
32832155 | Renal Tubular Cells from Hibernating Squirrels are Protected against Cisplatin Induced Apoptosis. | 2020 |
1 |
| 127 |
32862611 | Davanone terpenoid inhibits cisplatin-resistant acute myeloid leukemia cancer cell growth by inducing caspase-dependent apoptosis, loss of mitochondrial membrane potential, inhibition of cell migration and invasion and targeting PI3K/AKT/MAPK signalling pathway. | 2020 May-Jun |
1 |
| 128 |
32867831 | Boswellic acid sensitizes gastric cancer cells to Cisplatin-induced apoptosis via p53-mediated pathway. | 2020 Sep 1 |
2 |
| 129 |
32945421 | Panax notoginseng Saponins protect auditory cells against cisplatin‑induced ototoxicity by inducing the AKT/Nrf2 signaling‑mediated redox pathway. | 2020 Oct |
2 |
| 130 |
32945500 | Inactivation of AKT/NF‑κB signaling by eurycomalactone decreases human NSCLC cell viability and improves the chemosensitivity to cisplatin. | 2020 Oct |
8 |
| 131 |
32948132 | FUT4siRNA augments the chemosensitivity of non-small cell lung cancer to cisplatin through activation of FOXO1-induced apoptosis. | 2020 Sep 18 |
1 |
| 132 |
32974127 | p53 Affects PGC1α Stability Through AKT/GSK-3β to Enhance Cisplatin Sensitivity in Non-Small Cell Lung Cancer. | 2020 |
1 |
| 133 |
33015030 | Valproic Acid Synergizes With Cisplatin and Cetuximab in vitro and in vivo in Head and Neck Cancer by Targeting the Mechanisms of Resistance. | 2020 |
1 |
| 134 |
33024577 | Arsenic trioxide enhances the chemotherapeutic efficiency of cisplatin in cholangiocarcinoma cells via inhibiting the 14-3-3ε-mediated survival mechanism. | 2020 |
2 |
| 135 |
33061807 | Lnc-MCEI mediated the chemosensitivity of esophageal squamous cell carcinoma via miR-6759-5p to competitively regulate IGF2. | 2020 |
1 |
| 136 |
33067427 | Cordycepin enhances the chemosensitivity of esophageal cancer cells to cisplatin by inducing the activation of AMPK and suppressing the AKT signaling pathway. | 2020 Oct 16 |
1 |
| 137 |
33112540 | Effect of Combined Sorafenib/Cisplatinum Treatment on the Autophagy and Proliferation of Hepatocellular Carcinoma hepG2 Cells in Vitro. | 2020 Oct 1 |
2 |
| 138 |
33115978 | Long Noncoding RNA HOXA11-AS Modulates the Resistance of Nasopharyngeal Carcinoma Cells to Cisplatin via miR-454-3p/c-Met. | 2020 Oct 31 |
1 |
| 139 |
33123242 | Synergistic antitumor effect of dual PI3K and mTOR inhibitor NVP-BEZ235 in combination with cisplatin on drug-resistant non-small cell lung cancer cell. | 2020 Dec |
1 |
| 140 |
33167006 | FOXO1 and FOXO3a sensitize non-small-cell lung cancer cells to cisplatin-induced apoptosis independent of Bim. | 2020 Dec 29 |
1 |
| 141 |
33227065 | AKT isoforms have discrete expression in triple negative breast cancers and roles in cisplatin sensitivity. | 2020 Nov 10 |
1 |
| 142 |
33244267 | Circadian Clock Protein PERIOD2 Suppresses the PI3K/Akt Pathway and Promotes Cisplatin Sensitivity in Ovarian Cancer. | 2020 |
1 |
| 143 |
33362566 | Berberine Improves Chemo-Sensitivity to Cisplatin by Enhancing Cell Apoptosis and Repressing PI3K/AKT/mTOR Signaling Pathway in Gastric Cancer. | 2020 |
2 |
| 144 |
33520990 | Cordycepin Reverses Cisplatin Resistance in Non-small Cell Lung Cancer by Activating AMPK and Inhibiting AKT Signaling Pathway. | 2020 |
1 |
| 145 |
33614623 | Parthenolide Augments the Chemosensitivity of Non-small-Cell Lung Cancer to Cisplatin via the PI3K/AKT Signaling Pathway. | 2020 |
1 |
| 146 |
33817712 | Adjuvant effects of chemotherapeutics and Metformin on MFE-319 endometrial carcinoma cell line. | 2020 Jul-Sep |
1 |
| 147 |
30296564 | TCF21 inhibits proliferation and chemoresistance through the AKT pathway in human gastric cancer. | 2019 Jan 15 |
1 |
| 148 |
30316146 | Preclinical In Vitro and In Vivo Evidence of an Antitumor Effect of CX-4945, a Casein Kinase II Inhibitor, in Cholangiocarcinoma. | 2019 Jan |
1 |
| 149 |
30417422 | Inactivation of ADAMTS18 by aberrant promoter hypermethylation contribute to lung cancer progression. | 2019 May |
2 |
| 150 |
30483742 | Tunicamycin enhances the suppressive effects of cisplatin on lung cancer growth through PTX3 glycosylation via AKT/NF-κB signaling pathway. | 2019 Feb |
1 |